Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare
The aim of review. To present the diagnostic and treatment algorithm for abdominal pain at out-patient/ polyclinic healthcare institutions and to demonstrate potential of hyoscine butylbromide application during diagnostic process and for relief of abdominal pain at irritable bowel syndrome.Summary....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2015-12-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1045 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860141674463232 |
|---|---|
| author | Yu. A. Kucheryavy T. L. Lapina M. A. Livzan M. F. Osipenko |
| author_facet | Yu. A. Kucheryavy T. L. Lapina M. A. Livzan M. F. Osipenko |
| author_sort | Yu. A. Kucheryavy |
| collection | DOAJ |
| description | The aim of review. To present the diagnostic and treatment algorithm for abdominal pain at out-patient/ polyclinic healthcare institutions and to demonstrate potential of hyoscine butylbromide application during diagnostic process and for relief of abdominal pain at irritable bowel syndrome.Summary. From 20% to 50% of all admissions to medical institutions are related to abdominal spasms and pain caused by irritable bowel syndrome (IBS). According to the Clinical guidelines of the Russian gastroenterological association and abdominal pain management algorithm at outpatient reception, the doctor on the basis of interviewing, inspection and physical data first of all should exclude acute abdominal diseases (acute pain, parietal pain) requiring urgent examination by the surgeon or gynecologist and subsequent hospitalization. In the case of visceral pain the minimal range of laboratory and instrumental tests is indicated. If the history of visceral pain is more than 6 months and there are no alarm symptoms, doctor should define specific features of clinical presentation already during outpatient visit, taking into account pain location, that provides formulation of preliminary diagnosis. Epigastric pain (dyspepsia), biliary pain, abdominal pain which can be accompanied by impaired frequency and consistency of stool determine the further investigation plan. Implementation of diagnostic algorithm allows to distinguish the organic disease or to establishthe diagnosis of functional disease. Hyoscine butylbromide at short-term treatment will relieve abdominal spasm as a symptomatic agent. Course treatment effectively reduces intensity and frequency of abdominal pain at IBS. The rate of adverse events and tolerability of hyoscine butylbromide are comparable to that of placebo.Conclusion. Symptomatic treatment by antispasmodic drugs is justified from the moment of referral for medical aid to outpatient department. Hyoscine butylbromide can be prescribed for relief of acute and chronic pain at any stage of diagnostic process. Course intake of antispasmodics has proved its efficacy for pain relief at IBS. |
| format | Article |
| id | doaj-art-8d9aa1473b374b12920d36c63a8e43d0 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2015-12-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-8d9aa1473b374b12920d36c63a8e43d02025-02-10T16:14:34ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732015-12-01256103109651Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcareYu. A. Kucheryavy0T. L. Lapina1M. A. Livzan2M. F. Osipenko3State educational government-financed institution of higher professional education «Yevdokimov Moscow State University of Medicine and Dentistry», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Omsk state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Novosibirsk state medical university», Ministry of Healthcare of the Russian FederationThe aim of review. To present the diagnostic and treatment algorithm for abdominal pain at out-patient/ polyclinic healthcare institutions and to demonstrate potential of hyoscine butylbromide application during diagnostic process and for relief of abdominal pain at irritable bowel syndrome.Summary. From 20% to 50% of all admissions to medical institutions are related to abdominal spasms and pain caused by irritable bowel syndrome (IBS). According to the Clinical guidelines of the Russian gastroenterological association and abdominal pain management algorithm at outpatient reception, the doctor on the basis of interviewing, inspection and physical data first of all should exclude acute abdominal diseases (acute pain, parietal pain) requiring urgent examination by the surgeon or gynecologist and subsequent hospitalization. In the case of visceral pain the minimal range of laboratory and instrumental tests is indicated. If the history of visceral pain is more than 6 months and there are no alarm symptoms, doctor should define specific features of clinical presentation already during outpatient visit, taking into account pain location, that provides formulation of preliminary diagnosis. Epigastric pain (dyspepsia), biliary pain, abdominal pain which can be accompanied by impaired frequency and consistency of stool determine the further investigation plan. Implementation of diagnostic algorithm allows to distinguish the organic disease or to establishthe diagnosis of functional disease. Hyoscine butylbromide at short-term treatment will relieve abdominal spasm as a symptomatic agent. Course treatment effectively reduces intensity and frequency of abdominal pain at IBS. The rate of adverse events and tolerability of hyoscine butylbromide are comparable to that of placebo.Conclusion. Symptomatic treatment by antispasmodic drugs is justified from the moment of referral for medical aid to outpatient department. Hyoscine butylbromide can be prescribed for relief of acute and chronic pain at any stage of diagnostic process. Course intake of antispasmodics has proved its efficacy for pain relief at IBS.https://www.gastro-j.ru/jour/article/view/1045abdominal painabdominal spasmirritable bowel syndromehyoscine butylbromide |
| spellingShingle | Yu. A. Kucheryavy T. L. Lapina M. A. Livzan M. F. Osipenko Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare Российский журнал гастроэнтерологии, гепатологии, колопроктологии abdominal pain abdominal spasm irritable bowel syndrome hyoscine butylbromide |
| title | Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare |
| title_full | Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare |
| title_fullStr | Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare |
| title_full_unstemmed | Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare |
| title_short | Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare |
| title_sort | issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare |
| topic | abdominal pain abdominal spasm irritable bowel syndrome hyoscine butylbromide |
| url | https://www.gastro-j.ru/jour/article/view/1045 |
| work_keys_str_mv | AT yuakucheryavy issuesofdiagnosticsandtreatmentofabdominalpainatirritablebowelsyndromeatoutpatientstageofthehealthcare AT tllapina issuesofdiagnosticsandtreatmentofabdominalpainatirritablebowelsyndromeatoutpatientstageofthehealthcare AT malivzan issuesofdiagnosticsandtreatmentofabdominalpainatirritablebowelsyndromeatoutpatientstageofthehealthcare AT mfosipenko issuesofdiagnosticsandtreatmentofabdominalpainatirritablebowelsyndromeatoutpatientstageofthehealthcare |